Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 163

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 163
---
 on such solicitations.

Direct Sales

We may also sell securities directly to one or
more purchasers without using underwriters or agents. Underwriters, dealers and agents that participate in the distribution of the securities
may be underwriters as defined in the Securities Act and any discounts or commissions they receive from us and any profit on their resale
of the securities may be treated as underwriting discounts and commissions under the Securities Act. We will identify in the accompanying
prospectus supplement any underwriters, dealers or agents and will describe their compensation. We may have agreements with the underwriters,
dealers and agents to indemnify them against specified civil liabilities, including liabilities under the Securities Act. Underwriters,
dealers and agents may engage in transactions with or perform services for us in the ordinary course of their businesses from time to
time.

| 67 |

Underwriting Compensation

Any underwriting compensation paid by us to underwriters,
dealers or agents in connection with the offering of securities, and any discounts, concessions or commissions allowed by underwriters
to participating dealers, will be set forth in the applicable prospectus supplement. Dealers and agents participating in the distribution
of the securities may be deemed to be underwriters, and any discounts and commissions received by them and any profit realized by them
on resale of the securities may be deemed to be underwriting discounts and commissions under the Securities Act. In the event that FINRA
Rule 5121 applies to any such offering due to the presence of a “conflict of interest” (as that term is defined in FINRA Rule
5121), the prospectus supplement for that offering will contain prominent disclosure with respect to such conflict of interest as required
by that rule. Underwriters, dealers and agents may be entitled, under agreements entered into with us and our operating partnership, to
indemnification against and contribution toward civil liabilities, including liabilities under the Securities Act. We will describe any
indemnification agreement in the applicable prospectus supplement.

Trading Markets and Listing of Securities

Unless otherwise specified in the accompanying
prospectus supplement, each class or series of securities covered by this prospectus will be a new issue with no established trading market,
other than our common stock and our Series A Preferred Stock, which are listed on the NYSE. We may elect to list any other class or series
of securities on any exchange, but we are not obligated to do so. It is possible that one or more underwriters may make a market in a
class or series of